Top

Quality of Life Research

Gepubliceerd in:

01-02-2014

The development and validation of the Family Reported Outcome Measure (FROM-16)^© to assess the impact of disease on the partner or family member

Auteurs: Catherine Jane Golics, Mohammad Khurshid Azam Basra, Andrew Yule Finlay, Sam Salek

Gepubliceerd in: Quality of Life Research | Uitgave 1/2014

Abstract

Purpose

The impact of patients’ illness on family members has proven to be both widespread and severe. Currently, there is no generic instrument that can be used to measure the impact of illnesses on the partner or family members of patients. This study describes the development of the Family Reported Outcome Measure (FROM-16)^©.

Methods

A total of 30 items were generated from the content of previous interviews with family members. Qualitative and quantitative feedback from expert panels was collected. Items were reduced using both Rasch analysis and factor analysis, and full psychometric testing was carried out including construct validity and reliability.

Results

Collapsing response categories, removing misfitting items and combining residually correlating items produced a good fit to the Rasch model (n = 240, total χ ² = 56.6, df = 48, p = 0.18). Factor analysis produced a 16-item measure with two factors. The FROM showed high internal consistency (n = 120, Cronbach’s α = 0.80–0.89), high reproducibility (n = 51, intraclass correlation = 0.85–0.92) and a mean completion time of 2 min. Construct validity was proven through the correlation between the FROM and the WHOQOL-BREF total scores (n = 119, r = −0.53–0.52, p < 0.001), and the correlation between the FROM and the patient’s overall health score (n = 120, r = −0.45–0.48, p < 0.001).

Conclusion

The FROM-16 is both reliable and valid for use. It has a potential for wide use, including clinical (healthcare professionals or researchers in all medical specialties), industrial and social sciences. The FROM can be used to identify areas where family members need further support, as well as identify those individuals most affected by the patient’s illness.

vorige artikel The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patients

volgende artikel Few items in the thyroid-related quality of life instrument ThyPRO exhibited differential item functioning

Basra, M. K., Sue-Ho, R., & Finlay, A. Y. (2007). The Family Dermatology Life Quality Index: Measuring the secondary impact of skin disease. British Journal of Dermatology, 156(3), 528–538.PubMedCrossRef

Swanberg, J. E. (2006). Making it work: Informal caregiving, cancer, and employment. Journal of Psychosocial Oncology, 24(3), 1–18.PubMedCrossRef

Poston, D., Turnbull, A., Park, J., Mannan, H., Marquis, J., & Wang, M. (2003). Family quality of life: A qualitative inquiry. Mental Retardation, 41(5), 313–328.PubMedCrossRef

Basra, M. K., & Finlay, A. Y. (2007). The family impact of skin diseases: The Greater Patient concept. British Journal of Dermatology, 156(5), 929–937.PubMedCrossRef

Kornblith, A. B., Herr, H. W., Ofman, U. S., Scher, H. I., & Holland, J. C. (1994). Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer, 73(11), 2791–2802.PubMedCrossRef

Rees, J., O’Boyle, C., & MacDonagh, R. (2001). Quality of life: Impact of chronic illness on the partner. Journal of the Royal Society of Medicine, 94(11), 563–566.PubMedCentralPubMed

Breau, G. M., Camfield, C. S., Camfield, P. R., & Breau, L. M. (2008). Evaluation of the responsiveness of the Impact of Pediatric Epilepsy Scale. Epilepsy and Behaviour, 13(3), 454–457.CrossRef

Ben-Gashir, M. A., Seed, P. T., & Hay, R. J. (2002). Are quality of family life and disease severity related in childhood atopic dermatitis? Journal of the European Academy of Dermatology and Venereology, 16(5), 455–462.PubMedCrossRef

Golics, C. J., Basra, M. K. A., Finlay, A. Y., & Salek, M. S. (2013). The impact of disease on family members: A critical aspect of medical care. Journal of the Royal Society of Medicine (in press).

10.

Golics, C. J., Salek, M. S., Basra, M. K. A., & Finlay, A. Y. (2013). The impact of patients’ disease on family quality of life: An experience from 26 specialties. Journal of the Royal Society of Medicine. doi:10.1177/0141076812472616.

11.

Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299–310.PubMedCrossRef

12.

Flesch, R. (1948). A new readability yardstick. Journal of Applied Psychology, 32(3), 221–233.PubMedCrossRef

13.

Haynes, N. S., Richard, D. C. S., & Kubany, E. S. (1995). Content validity in psychological assessment: A functional approach to concepts and methods. Psychological Assessment, 7(3), 238–247.CrossRef

14.

Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Kline Leidy, N. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648–654.PubMedCrossRef

15.

Pallant, J. F., & Tennant, A. (2007). An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). British Journal of Clinical Psychology, 46(Pt 1), 1–18.PubMedCrossRef

16.

Hansen, T., Lambert, H. C., & Faber, J. (2012). Validation of the Danish version of the McGill Ingestive Skills Assessment using classical test theory and the Rasch model. Disability and Rehabilitation, 34(10), 859–868.PubMedCrossRef

17.

Fisher, W. P. (1992). Reliability statistics. Rasch Measurement Transactions, 6(3), 238.

18.

Fabrigar, L. R., Wegener, D. T., MacCallum, R. C., & Strahan, E. J. (1999). Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods, 4(3), 272–299.CrossRef

19.

Pallant, J. F. (2005). SPSS survival manual: A step-by-step guide to data analysis using SPSS for Windows (Version 12) (2nd ed.). In J. F. Pallant. Maidenhead: Open University Press.

20.

Cattell, R. B. (1966). The scree test for number of factors. Multivariate Behavioural Research, 1(2), 245–276.CrossRef

21.

Finch, H. (2006). Comparison of the performance of varimax and promax rotations: Factor structure recovery for dichotomous items. Journal of Educational Measurement, 43, 39–52.CrossRef

22.

Cronbach, L. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297–334.CrossRef

23.

Streiner, D. L., & Norman, G. R. (2008). Health Measurement Scales: A practical guide to their development and use (4th ed.). Oxford: Oxford University Press.CrossRef

24.

Nunnally, J. C. (1978). Psychometric theory (2nd ed.). New York: McGraw-Hill.

25.

Issacs, B. J., Brown, I., Brown, R. I., Baum, N., Myerscough, T., Neikrug, S., et al. (2007). The international family quality of life project: Goals and description of a survey tool. Journal of Policy and Practice in Intellectual Disabilities, 4(3), 177–185.CrossRef

26.

Stein, R. E., & Riessman, C. K. (1980). The development of an impact-on-family scale: Preliminary findings. Medical Care, 18(4), 465–472.PubMedCrossRef

27.

Golics, C. J., Basra, M. K. A., Salek, M. S., & Finlay, A. Y. (2011). Diseases profoundly affect the quality of life of family members of patients. The Journal of Investigative Dermatology, 131(Suppl 2), S39.

28.

Grant, J. S., & Davis, L. L. (1997). Selection and use of content experts for instrument development. Research in Nursing & Health, 20(3), 269–274.CrossRef

29.

Uhlig, T., Lillemo, S., Moe, R. H., Stamm, T., Cieza, A., Boonen, A., et al. (2007). Reliability of the ICF core set for rheumatoid arthritis. Annals of the Rheumatic Diseases, 66(8), 1078–1084.PubMedCrossRef

30.

Heppner, P. P., Kivlighan, D. M., & Wampold, B. E. (1992). Research design in counseling. Pacific Grove, CA: Brooks/Cole.

31.

Clark, L. A., & Watson, D. (1995). Constructing validity: Basic issues in objective scale development. Psychological Assessment, 7(3), 309–319.CrossRef

32.

Ponterotto, J. G., & Ruckdeschel, D. E. (2007). An overview of coefficient alpha and a reliability matrix for estimating adequacy of internal consistency coefficients with psychological research measures. Perceptual and Motor Skills, 105(3 Pt 1), 997–1014.PubMed

33.

Housman, T. S., Patel, M. J., Camacho, F., Feldman, S. R., Fleischer, A. B., Jr, & Balkrishnan, R. (2002). Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: Results of a validation study. British Journal of Dermatology, 147(6), 1192–1198.PubMedCrossRef

34.

Ware, J. E., Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef

Titel: The development and validation of the Family Reported Outcome Measure (FROM-16)© to assess the impact of disease on the partner or family member
Auteurs: Catherine Jane Golics
Mohammad Khurshid Azam Basra
Andrew Yule Finlay
Sam Salek
Publicatiedatum: 01-02-2014
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 1/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-013-0457-y

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2014

Does self-management counseling in patients with heart failure improve quality of life? Findings from the Heart Failure Adherence and Retention Trial (HART)

Testing measurement invariance of the patient-reported outcomes measurement information system pain behaviors score between the US general population sample and a sample of individuals with chronic pain

Depression and painful conditions: patterns of association with health status and health utility ratings in the general population

Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms

Innovations in e-health

Poor self-rated health associated with an increased risk of subsequent development of lung cancer